Scientific Reports 6: Article number: 2401410.1038/srep24014; published online: April012016; updated: July112016
This Article contains errors in Table 1, where the column headings ‘Without SMs (n = 105)’ and ‘With SMs (n = 23) are inverted. The correct Table 1 appears below.
Table 1. Clinical characteristics of HNSCC patients in a 13 years of follow-up cohort.
| Characteristics | HNSCC male patients (n = 128) | P value | |
|---|---|---|---|
| With SMs (n = 23) | Without SMs (n = 105) | ||
| Age (years, mean ± SD) | 52.8 ± 12.2 | 51.3 ± 10.6 | 0.56 |
| Primary cancer site | |||
| Buccal | 7 (30.4%) | 48 (45.7%) | 0.83 |
| Tongue | 9 (39.1%) | 33 (31.4%) | |
| Gum | 3 (12.0%) | 12 (11.4%) | |
| Palate | 2 (8.7%) | 5 (4.8%) | |
| Lip | 1 (4.3%) | 2 (1.9%) | |
| Oropharynx | 1 (4.3%) | 2 (1.9%) | |
| Hypopharynx | 0 (0.0%) | 1 (1.0%) | |
| Larynx | 0 (0.0%) | 1 (1.0%) | |
| Stage | |||
| I | 4 (17.4%) | 15 (14.3%) | 0.79 |
| II | 3 (13.0%) | 24 (22.9%) | |
| III | 6 (26.1%) | 27 (25.7%) | |
| IV | 9 (39.1%) | 38 (36.2%) | |
| Radiotherapy | |||
| Yes | 14 (60.9%) | 71 (67.6%) | 0.51 |
| No | 8 (34.8%) | 27 (25.7%) | |
| Chemotherapy | |||
| Yes | 11 (47.8%) | 58 (55.2%) | 0.28 |
| No | 12 (52.2%) | 43 (41.0%) | |
| Recurrence | |||
| Yes | 12 (52.2%) | 27 (25.7%) | 0.02 |
| No | 11 (47.8%) | 78 (74.3%) | |
| Fatality | |||
| Yes | 7 (30.4%) | 15 (14.3%) | 0.06 |
| No | 16 (69.6%) | 90 (85.7%) | |